Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Fly Intel: Wall Street's top stories for Friday » 16:30
04/03/20
04/03
16:30
04/03/20
16:30
MMM

3M

$133.90 /

-3.96 (-2.87%)

, TSLA

Tesla

$479.71 /

+25.715 (+5.66%)

, BBBY

Bed Bath & Beyond

$3.94 /

+0.385 (+10.83%)

, BAC

Bank of America

$20.03 /

-0.535 (-2.60%)

, JPM

JPMorgan

$84.08 /

-1.57 (-1.83%)

, WFC

Wells Fargo

$26.23 /

-0.98 (-3.60%)

, C

Citi

$37.48 /

-1.82 (-4.63%)

, AMZN

Amazon.com

$1,905.62 /

-11.4 (-0.59%)

, WMT

Walmart

$119.37 /

+0.74 (+0.62%)

, FATE

Fate Therapeutics

$22.94 /

+1.87 (+8.88%)

, JNJ

Johnson & Johnson

$134.13 /

+1.05 (+0.79%)

, INCY

Incyte

$78.69 /

+1.68 (+2.18%)

, MIC

Macquarie Infrastructure

$18.23 /

-5.79 (-24.10%)

, AEHR

Aehr Test Systems

$1.27 /

-0.36 (-22.09%)

, CHWY

Chewy

$33.27 /

-1.995 (-5.66%)

The S&P 500 ended…

Open Full Text

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Opening call sale in Pfizer struck 7.4% above spot » 13:30
04/03/20
04/03
13:30
04/03/20
13:30
PFE

Pfizer

$33.42 /

+0.57 (+1.74%)

Opening call sale in…

Opening call sale in Pfizer struck 7.4% above spot. Shares up 2% today near $33.50 with a large trade on the ISE where a customer sold 10K June 36 calls for 91c to open a new position. Trade details show the sale was made in the form of an electronic auction, with a single buyer paying 2c above the 89c best bid for the order.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:28
04/03/20
04/03
12:28
04/03/20
12:28
MMM

3M

$133.94 /

-3.92 (-2.84%)

, TSLA

Tesla

$480.37 /

+26.38 (+5.81%)

, JPM

JPMorgan

$83.84 /

-1.81 (-2.11%)

, BAC

Bank of America

$19.78 /

-0.785 (-3.82%)

, C

Citi

$37.30 /

-2 (-5.09%)

, GS

Goldman Sachs

$145.44 /

-4.5 (-3.00%)

, MS

Morgan Stanley

$33.05 /

-0.84 (-2.48%)

, USB

U.S. Bancorp

$31.42 /

-1.29 (-3.94%)

, WFC

Wells Fargo

$26.11 /

-1.1 (-4.04%)

, BBBY

Bed Bath & Beyond

$3.53 /

-0.025 (-0.70%)

, FATE

Fate Therapeutics

$23.38 /

+2.31 (+10.96%)

, JNJ

Johnson & Johnson

$132.93 /

-0.15 (-0.11%)

, INCY

Incyte

$78.37 /

+1.36 (+1.77%)

, MIC

Macquarie Infrastructure

$17.68 /

-6.34 (-26.39%)

, AEHR

Aehr Test Systems

$1.38 /

-0.25 (-15.34%)

, CHWY

Chewy

$33.61 /

-1.655 (-4.69%)

The S&P and Dow are…

Open Full Text

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Piper Sandler biopharma analysts to hold an analyst/industry conference call » 10:25
04/03/20
04/03
10:25
04/03/20
10:25
GILD

Gilead

$78.61 /

+1.65 (+2.14%)

, MYL

Mylan

$14.25 /

+0.34 (+2.44%)

, TEVA

Teva

$8.55 /

+0.43 (+5.30%)

, AMRX

Amneal Pharmaceuticals

$3.02 /

-0.025 (-0.82%)

, ABBV

AbbVie

$74.23 /

-0.895 (-1.19%)

, REGN

Regeneron

$498.01 /

-0.74 (-0.15%)

, ALNY

Alnylam

$102.80 /

-1.58 (-1.51%)

, MRNA

Moderna

$33.88 /

+0.68 (+2.05%)

, INO

Inovio

$7.31 /

-0.19 (-2.53%)

Biopharma Analysts…

Biopharma Analysts Amsellem and Raymond, along with a physician based at the University of Pisa Hospital in Pisa, Italy, who has managed over 100 COVID-19 patients and provides his perspective where New York area could be in 2-3 weeks, on an Analyst/Industry conference call to be held on April 3 at 11 am.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Cantor pharma/biotech analysts to hold analyst/industry conference call » 10:21
04/03/20
04/03
10:21
04/03/20
10:21
PFE

Pfizer

$33.66 /

+0.81 (+2.47%)

, LLY

Eli Lilly

$142.95 /

+0.8 (+0.56%)

, MRK

Merck

$77.00 /

+0.09 (+0.12%)

, MRTX

Mirati Therapeutics

$76.21 /

+0.84 (+1.11%)

, AMGN

Amgen

$207.69 /

-1.35 (-0.65%)

, JNJ

Johnson & Johnson

$133.95 /

+0.87 (+0.65%)

, PHGE

BiomX

$7.00 /

+ (+0.00%)

Cantor Fitzgerald…

Cantor Fitzgerald Pharmaceuticals Analyst Chen & Kim, Biotech Analysts Young, Kumar & Kluska, along with Dr. Robert Fine from New York-Presbyterian/Columbia University Medical Center review current treatment paradigm for advanced and metastatic colorectal cancer (CRC) and discuss new treatments for CRC on an Analyst/Industry conference call to be held on April 6 at 11 am.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Stifel says Seattle Genetics FDA talks on EV positive, but not surprising » 09:25
04/03/20
04/03
09:25
04/03/20
09:25
SGEN

Seattle Genetics

$118.68 /

+7.43 (+6.68%)

Stifel analyst Stephen…

Stifel analyst Stephen Willey said Seattle Genetics' disclosure of recent talks with the FDA suggesting a potential pathway to accelerated approval for enfortumab vedotin, or EV, in combination with pembrolizumab in front-line/cisplatin-ineligible mUC patients is "incrementally positive, but not terribly surprising" given the recently-secured Breakthrough Therapy Designation for this indication. He already assumes "a non-insignificant contribution" of EV sales derived from the first-line setting in FY21 and is "inclined to believe some of this upside" is similarly reflected in consensus estimates, said Willey, who keeps a Hold rating on the shares.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Icon signs new service agreement with Pfizer » 09:14
04/03/20
04/03
09:14
04/03/20
09:14
ICLR

Icon

$129.69 /

-2.86 (-2.16%)

, PFE

Pfizer

$32.85 /

+1.12 (+3.53%)

ICON (ICLR) announced it…

ICON (ICLR) announced it has signed a three-year agreement with Pfizer (PFE). Under the terms of the agreement, Pfizer has the right to extend the term for up to an additional two years. Financial details of the agreement were not disclosed. The agreement builds on the companies' existing relationship, under which ICON provides global expertise in the planning, execution, management and conduct of clinical trials.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Guggenheim to hold a virtual conference » 09:07
04/03/20
04/03
09:07
04/03/20
09:07
RCKT

Rocket Pharmaceuticals

$14.18 /

+0.85 (+6.38%)

, ZEAL

Zealand Pharma

$30.95 /

-0.65 (-2.06%)

Healthcare Talks: Genomic…

Healthcare Talks: Genomic Medicines & Rare Diseases 2020 to be held on April 3.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
BioNTech price target raised to $60 from $22 at Canaccord » 08:54
04/03/20
04/03
08:54
04/03/20
08:54
BNTX

BioNTech

$56.05 /

+3.07 (+5.79%)

, PFE

Pfizer

$32.85 /

+1.12 (+3.53%)

Canaccord analyst Arlinda…

Canaccord analyst Arlinda Lee raised the firm's price target on BioNTech (BNTX) to $60 from $22 and keeps a Buy rating on the shares.The analyst noted its COVID-19 vaccine candidate which is partnered with Pfizer (PFE) will enter the clinic in April as the company continues to advance its pipeline.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Novartis says 'deeply dedicated' to global effort to combat COVID-19 » 06:18
04/03/20
04/03
06:18
04/03/20
06:18
NVS

Novartis

$83.52 /

+2.55 (+3.15%)

Novartis said it is…

Novartis said it is "deeply dedicated" to the global effort to combat COVID-19 and "doing our part to support the stability of global healthcare systems. We announced a broad set of measures including the creation of a global fund of $20M to support communities around the world impacted by the COVID-19 pandemic. Novartis also has committed 130 million doses of hydroxychloroquine to support pandemic response. In addition, Novartis joined two key cross-industry research initiatives, the COVID-19 Therapeutics Accelerator, coordinated by the Bill & Melinda Gates Foundation, Wellcome, and Mastercard, as well as a COVID-19 directed partnership organized by the Innovative Medicines Initiative. Novartis is separately supporting COVID-19 related clinical investigations of several Novartis medicines. To support access, the Novartis generics and biosimilars division Sandoz became the first company to commit to keeping stable prices for a basket of essential medicines that may help in the treatment of COVID-19."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.